Introduction {#Sec1}
============

Lectins, or carbohydrate-binding proteins, are present in various organisms from viruses to mammals and serve as recognition molecules between cells, cell and matrix, and organisms. Owing to the capability of discriminating carbohydrate structures, not only are lectins used as valuable biochemical reagents in many research fields, including glycomics, but they are promising candidates for medicinal and clinical application (Sharon and Lis [@CR41]). Indeed, antiviral activities have been reported for several lectins (Botos and Wlodawer [@CR7]). Antihuman immunodeficiency virus (HIV) and/or anti-influenza virus lectins from bacteria, algae, fungi, and land plants have the common property of binding to high-mannose *N*-glycans, thereby blocking the entry of viruses into host cells through binding to the mannoside structures in the viral envelope glycoproteins, which are critical for the primary infection of viruses (Balzarini [@CR3]). The anti-HIV lectins from cyanobacteria (blue-green algae) and eukaryotic macroalgae are presently marked as a new antiviral agent because their HIV-inhibiting activities are extremely strong compared to those of lectins from other biological groups (Ziólkowska and Wlodawer [@CR47]; Balzarini [@CR4]). Practically, a potent anti-HIV lectin, griffithsin, from the red alga *Griffithsia* sp., has been investigated in detail with this objective (Mori et al. [@CR29]), as well as some anti-HIV cyanobacterial lectins (Ziólkowska and Wlodawer [@CR47]; Sato et al. [@CR37]). Recently, the high-mannose *N*-glycan-specific lectins from the red alga *Kappaphycus alvarezii* (KAA-2) (Sato et al. [@CR38]) and the green alga *Boodlea coacta* (BCA) (Sato et al. [@CR39]) showed strong anti-HIV and anti-influenza virus activities in a similar manner. Although these anti-HIV lectins share both binding specificity for high-mannose *N*-glycans and repeated domain structures, they differ from each another in amino acid sequences and recognizing branched mannoside structures, which may lead to subtle differences in the degree of inhibiting activities. Some of high-mannose binding lectins also inhibit the infection of other enveloped viruses such as Ebola virus (Barrientos et al. [@CR5]), hepatitis C virus (HCV) (Helle et al. [@CR13]), and severe acute respiratory syndrome coronavirus (SARS-CoV) (O'Keefe et al. [@CR32]). Thus, high-mannose binding lectins may become a useful interesting target for application. Furthermore, antibacterial activities have been reported for lectins from various biological sources (Slifkin and Doyle [@CR42]). However, little is known about the effects of marine algal lectins towards marine vibrios, except the species-specific activities against vibrios have been reported for the lectins from the red algae, *Eucheuma serra* and *Galaxaura marginata* (Liao et al. [@CR26]). Marine vibrios are halophilic Gram-negative proteobacteria, which occupy a diverse range of ecological niches including sediments, water column, and in association with organisms either as symbionts or pathogens (Tracy et al. [@CR44]). They cause an economically important disease of fish, marine invertebrates, and are responsible for high mortality rates in aquaculture worldwide (Marhual et al. [@CR28]). Among the vibrios, *Vibrio alginolyticus* and *V. parahaemolyticus* are quite important, since they cause serious episodes in marine fish and shellfish including shrimp (Zorrilla et al. [@CR48]; Marhual et al. [@CR28]). In Vietnam, *V. alginolyticus*, *V. parahaemolyticus*, and *V. harveyi* have greatly reduced yields of farmed shrimps (FAO [@CR12]).

The algae *Kappaphycus alvarezii*, *K. striatum*, and *Eucheuma denticulatum* are economically important species and extensively cultivated for edible purposes or as a source of carrageenophyte for industry. Those algal species have been introduced in more than 20 countries for mariculture purposes (Ask and Azanza [@CR1]). In Vietnam, *E. denticulatum* has been cultivated since 2005 from algal seeds that were transported from Bohol, Philippines. Although the high-mannose *N*-glycan-specific lectins from carrageenophytes have been reported, including ESA-2 from *Eucheuma serra* (Hori et al. [@CR17]), KAA-2 from *K. alvarezii* (Sato et al. [@CR38]), and KSA-2 from *K. striatum* (Hung et al. [@CR20]), little is known about lectin from *E. denticulatum*, which can provide valuable information regarding lectins from this cultivated carrageenophytes, whose biological roles still remain elusive to a large extent. In a screening of hemagglutinins in Vietnamese marine algae, strong hemagglutination activity was detected in the extract of cultivated *E. denticulatum* (Hung et al. [@CR18]). The objective of this research was to evaluate the primary structure, the carbohydrate-binding specificity, and the biological properties including the antibacterial activities against the shrimp pathogenic vibrios of the lectin from cultivated *E. denticulatum* for future applications.

Materials and methods {#Sec2}
=====================

The red alga *Eucheuma denticulatum* (Burman) Collins et Harvey was collected in a farm at Vanphong Bay, Khanhhoa Province, Vietnam, brought to the laboratory, and kept at −20 °C until use. A small portion of the alga was stored at −20 °C in RNAlater (Invitrogen) until used for the RNA extraction. Prepacked columns were purchased; Superdex R-75 HR 10/30 from GE Healthcare (England), TSKgel DEAE-5PW, TSKgel NH~2~-60, and TSKgel ODS80TM from Tosoh Corporation (Japan), and YMC PROTEIN-RP from YMC (Japan). A GP SENSOR kit for detection of carbohydrate was purchased from Seikagaku Corporation (Japan). Monosaccharides and yeast mannan were from Nakarai Chemical (Japan). Fucoidan, transferrin, fetuin, asialo-fetuin, porcine thyroglobulin, bovine submaxillary mucin, and porcine stomach mucin were purchased from Sigma (USA). Bovine thyroglobulin was purchased from Wako (Japan). Asialo-derivatives of bovine thyroglobulin, porcine thyroglobulin, and bovine submaxillary mucin were prepared by hydrolysis of the parent sialoglycoprotein as described previously (Hung et al. [@CR20]). Pyridylaminated (PA)-oligosaccharides used in this study were obtained from Takara (Japan), except PA-derivatives of mannotriose (Man(α1-6)\[Man(α1-3)\]Man) and mannopentaose (Man(α1-6)\[Man(α1-3)\]Man(α1-6)\[Man(α1-3)\]Man). The latter two oligomannoses were purchased from Funakoshi (Japan) and pyridylaminated as described previously (Hori et al. [@CR17]). All other chemicals used in this study were of the highest purity available. Three species of shrimp pathogenic vibrios, *Vibrio alginolyticus*, *Vibrio parahaemolyticus*, and *Vibrio harveyi* were obtained from Institute of Aquaculture Research No. 3, Nhatrang, Vietnam.

Extraction and purification of lectins {#FPar1}
--------------------------------------

Extraction and purification procedures for lectins from *E. denticulatum* were performed by the same method as described previously for the lectins from *K. striatum* (Hung et al. [@CR20]). Briefly, a fresh sample (1 kg) of cultivated *E. denticulatum* was homogenized with equal volume (v/w) of 40 % aqueous EtOH (v/v) and kept at 4 °C for 18 h with occasional stirring. After filtration through a cheese cloth, the filtrate was centrifuged at 3500 × *g* for 20 min at 4 °C. The supernatant was collected and examined for hemagglutination activity. To the supernatant, cold absolute EtOH (−20 °C) was added to attain a final concentration of about 80 % as measured by an alcoholmeter and the mixture was kept at 4 °C overnight. The resulting precipitates were collected by centrifugation at 3500 × *g* for 30 min at 4 °C and thoroughly dialyzed against 50-mM phosphate buffer (pH 7.0) containing 0.15-M NaCl. The non-dialyzable fraction was applied to a Superdex R 75 HR column (10 × 300 mm) equilibrated with the above buffer. The column was eluted with the same buffer at a flow rate of 1.0 mL min^−1^. Active fractions were pooled, concentrated by ultrafiltration, and dialyzed against 20-mM Tris--HCl buffer (pH 8.0). The concentrate was subjected to ion-exchange chromatography on a TSKgel DEAE-5PW column (7.5 × 75 mm) equilibrated with 20-mM Tris--HCl buffer (pH 8.0). This elution was performed at a flow rate of 0.4 mL min^−1^, first with the same buffer for 3 min, then with a linear gradient between 0 and 0.16-M NaCl in the buffer for 22 min, and finally with 1-M NaCl in the buffer for 10 min. The eluate was monitored for absorbance at 280 nm and for hemagglutination activity with trypsin-treated rabbit erythrocytes. Active fractions were pooled and dialyzed against distilled H~2~O.

Determination of protein content {#FPar2}
--------------------------------

Protein contents were determined by the method of Lowry et al. ([@CR27]) using bovine serum albumin as a standard. Absorbance at 280 nm was also used to estimate protein contents in chromatographic fractions.

Determination of molecular mass and detection of carbohydrate {#FPar3}
-------------------------------------------------------------

The molecular masses of purified lectins were determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and electron spray ionization-mass spectrometry (ESI-MS) as described previously (Hung et al. [@CR20]). Briefly, the samples for SDS-PAGE were denatured at 100 °C for 5 min with or without 2 % 2-mercaptoethanol and then electrophored using a 10 % gel (Laemmli [@CR24]). After electrophoresis, the gel was stained with Coomassie Brilliant Blue R-250. Prior to determination of molecular mass by ESI-MS using a LCQ (Finnigan, USA), intact lectin was further purified by high-performance liquid chromatography (HPLC) on a YMC PROTEIN-RP column (6.0 × 250 mm) which had been equilibrated with 20 % acetonitrile in 0.1 % trifluoroacetic acid (TFA). After injection of the lectin sample, the column was washed with the starting solvent and then eluted with a linear gradient of acetonitrile from 20 to 70 % in 0.1 % TFA. The eluate was monitored for absorbance at 280 nm. The peak containing lectin was recovered and dried by a Speed Vac SC100 concentrator (Sarvant, USA). The purified sample was dissolved in 50 % acetonitrile in 0.1 % TFA and subjected to mass spectrometry. The parameters of ion source were as follows: Sheath(N~2~) gas, 70; aus (He) gas, 10; spray voltage, 4.5; capillary temperature, 220 °C; capillary voltage, 3 kV; tube lens offset, 10. Calibration was performed using ESA-2, a lectin protein that had been analyzed before in the same assay system (Hori et al. [@CR17]) and stocked in the laboratory. LCQ Bioworks (Finnigan, USA) was used to analyze and deconvolute the raw mass spectrum. For detection of glycoproteins, the electrophored gel was blotted to a PVDF membrane and the membrane was subjected to staining for carbohydrate using a GP SENSOR kit according to the manufacturer's instructions.

Analysis of N-terminal amino acid sequences {#FPar4}
-------------------------------------------

The N-terminal amino acid sequences of isolectins were determined by using a Procise 492 HT protein sequencing system (Applied Biosystems, USA). Before analyses, intact lectins were further purified by reversed-phase HPLC on a YMC PROTEIN-RP column as described before.

cDNA cloning of EDA {#FPar5}
-------------------

Total RNA was extracted from 2 g of RNAlater-treated alga using a Plant RNA Purification Reagent (Invitrogen, USA). Messenger RNA (mRNA) purification from the total RNA was performed using a NucleoTrap mRNA Mini kit (TaKaRa, Japan). Full-length complementary DNAs (cDNAs) were synthesized from 150 ng of mRNA using a GeneRacer kit (Invitrogen) according to the manufacturer's instructions.

The first polymerase chain reaction (PCR) for rapid amplification of the cDNA 3′end (3′RACE) was performed with eight aliquots of a 10-μL reaction mixture containing 1 μL of a 10 × Blend Taq buffer (Toyobo, Japan), 2 pmol of each deoxynucleotide triphosphate (dNTP), 6 pmol of the GeneRacer_3′\_Primer, 2 pmol of EDA_3′RACE_F1 primer, which was designed from the N-terminal amino acid sequence of EDAs (Table [1](#Tab1){ref-type="table"}), 0.2 μL of a 10-fold diluted synthesized cDNA, and 0.25 units of Blend Taq DNA polymerase (Toyobo). The reactions for eight aliquots were performed with a T Gradient Thermocycler (Biometra, Germany) under the following conditions: denaturation at 94 °C for 5 min, followed by 30 cycles consisting of denaturation at 94 °C for 30 s, annealing at eight different temperatures of 50--64 °C (2 °C increments) for 30 s, and extension at 72 °C for 1 min, and the final extension step at 72 °C for 5 min. The PCR products in eight aliquots were pooled, diluted to 100-fold, and then used as a template for nested PCR. The nested PCR was performed with a 50-μL reaction mixture containing 5 μL of a 10 × Blend Taq buffer, 10 pmol of each dNTP, 2 pmol of GeneRacer_3′\_Nested_Primer, 50 pmol of the degenerated primer EDA_3′RACE_d\_F2 which was designed from the conserved sequence among the high-mannose specific lectin family including ESA-2 (Hori et al. [@CR17]) and *Oscillatoria agardhii* (OAA) (Sato et al. [@CR37]), 1 μL of the dilution of the first PCR products, and 1.25 units of Blend Taq DNA polymerase. The nested PCR reaction was carried out by the same method of the first PCR, except for an annealing temperature of 60 °C. Nested PCR products were subcloned into pGEM-T Easy vector (Promega, USA) and transformed into *Escherichia coli* DH5α competent cells. Plasmids from the transformants were purified with a HiYield Plasmid Mini kit (RBC Bioscience, Taiwan) according to the manufacturer's instructions. DNA sequencing was performed by using BigDye Terminator Cycle Sequencing kit ver. 3.1 with an ABI 3130 × L genetic analyzer (Applied Biosystems).Table 1Primer sequence used in the cDNA cloning of EDA-2PrimerSequence (from 5′ to 3′)GeneRacer_3′\_Primer^a^GCTGTCAACGATACGCTACGTAACGGeneRacer_3′\_Nested_Primer^a^CGCTACGTAACGGCATGACAGTGGeneRacer_5′\_Primer^a^CGACTGGAGCACGAGGACACTGAGeneRacer_5′\_Nested_Primer^a^GGACACTGACATGGACTGAAGGAGTAEDA_3′RACE_F1AGAACCAGTGGGGAGGATCTEDA_3′RACE_d\_F1AYCAITAYAAYGTIGARAAYCARTGGGG^b^EDA_5′RACE_R1GCAATGTTCTTGGTAGCAGCEDA_5′end_FAGAAATTCAACACCACAACTEDA_3′end_RCTGCACAAAACGTAACAATATCTAT^a^These primers were inferred from the GeneRacer kit (Invitrogen)^b^Key to symbols of the degenerated nucleotides: I represents inosine, Y represents C and T, R represents A and G

The first PCR of 5′RACE was performed in the same way as 3′RACE as described above, except that GeneRacer_5′\_Primer and the primer EDA_3′end_R designed from the 3′ terminal sequence of EDA cDNA obtained by 3′RACE (Table [1](#Tab1){ref-type="table"}). The nested PCR was performed by the same method, except for using a 100-fold dilution of the first PCR products as a template, and the GeneRacer_5′\_Nested_Primer and the primer EDA_5′RACE_R1, designated from the sequence of EDA cDNA obtained by 3′RACE, as the primer pair (Table [1](#Tab1){ref-type="table"}). Subcloning and DNA sequencing were performed as described above.

To verify the sequence accuracy, full-length cDNA of EDA was further amplified by using a high-fidelity DNA polymerase KOD Plus Neo (Toyobo), a primer pair of EDA_3′end_R and EDA_5′end_F designated from the 5′ terminal sequence of EDA cDNA obtained by 5′RACE (Table [1](#Tab1){ref-type="table"}), and a 10-fold diluted synthesized cDNAs of *E. denticulatum* as a template, according to the manufacturer's instruction. Before subcloning, the PCR products were treated with a 10 × A-attachment mix (Toyobo) according to the manufacturer's instructions. Subcloning and DNA sequencing were then performed as described above.

Homologous sequences were identified with the basic local alignment search tool program (BLAST). The amino acid sequence comparison was performed using the CLUSTALW 2.0 program (Larkin et al. [@CR25]).

Hemagglutination activity and hemagglutination-inhibition test {#FPar6}
--------------------------------------------------------------

Hemagglutination activity and hemagglutination-inhibition test were determined with a 2 % (v/v) suspension of trypsin-treated rabbit erythrocytes (Hori et al. [@CR14]). Hemagglutination-inhibition was macroscopically observed and inhibition activity was expressed as the lowest concentration (mM or μg mL^−1^) of sugar or glycoprotein, at which a complete inhibition of four hemagglutination units was achieved. The sugars and glycoproteins used were D-glucose, D-mannose, D-galactose, L-rhamnose, L-fucose, D-xylose, GlcNAc, *N*-acetyl-D-galactosamine, *N*-acetyl-D-mannosamine, *N*-acetylneuraminic acid, lactose, and fucoidan as sugars, transferrin, fetuin, yeast mannan, porcine and bovine thyroglobulins, asialo-porcine and asialo-bovine thyroglobulins, bovine submaxillary mucin, asialo-bovine submaxillary mucin, and porcine stomach mucin as glycoproteins.

Effects of temperature, pH, and metal ions on hemagglutination activity {#FPar7}
-----------------------------------------------------------------------

The effects of temperature, pH, and metal ions on hemagglutination activity of isolated lectins were determined as described previously (Hori et al. [@CR14]).

Oligosaccharide-binding specificity by centrifugal ultrafiltration-HPLC assay {#FPar8}
-----------------------------------------------------------------------------

Of the isolectins purified from *E. denticulatum*, EDA-2 was selected to determine oligosaccharide-binding specificity using a centrifugal ultrafiltration-HPLC method (Hori et al. [@CR17]). Briefly, 500-nM EDA-2 (90 μL) in 50-mM Tris--HCl (pH 7.0) and 300-nM PA-oligosaccharide (10 μL) were mixed and kept at room temperature for 1 h. The reaction mixture was then ultrafiltered (10,000 × *g*, 30 s) using a centrifugal ultrafiltration tube (Nanospin Plus, Gelman Science, USA) having a molecular weight cut-off value of 10,000 Da to recover unreacted PA-oligosaccharides. An aliquot of filtrate was applied to a TSKgel ODS 80TM column (4.6 × 150 mm) and eluted with 10 % MeOH: 0.1-M ammonium acetate buffer (1:9, v/v) at a flow rate of 1.0 mL min^−1^ at 40 °C. The eluate was monitored at an excitation wavelength of 320 nm and an emission wavelength of 400 nm, and unbound PA-oligosaccharide (O~unbound~) was quantified. The amount of bound PA-oligosaccharide (O~bound~) was obtained by the following formula: O~bound~ = O~added~−O~unbound~, where O~added~ represents the amount of added PA-oligosaccharide, which was determined from the filtrate of reaction solution without a lectin. The binding activity (O~bound~/O~added~) was calculated as a ratio of the amount of bound PA-oligosaccharide to that of added and expressed as % binding.

Antibacterial activity and inhibition of antibacterial activity {#FPar9}
---------------------------------------------------------------

Antibacterial activity was determined by using a dilution procedure of a lectin solution in 20-mM phosphate buffer (pH 7.0) containing 0.85 % NaCl (PBS), based on the method of Charungchitrak et al. ([@CR10]). Three species of shrimp pathogenic marine bacteria, *V. harveyi*, *V. alginolyticus*, and *V. parahaemolyticus* were tested. An active peak fraction obtained by gel filtration, which included three isolectins from *E. denticulatum*, was used as a lectin solution (EDAs). The bacteria were grown in a sterilized seawater medium containing nutrient broth and yeast malt broth and incubated overnight in a shaker 37 °C. The cell concentration of bacteria was determined by measuring the suspension turbidity at 600 nm and converted to colony forming units (10^5^--10^6^ CFU mL^−1^) using a calibration curve. Serial twofold dilutions (100 μL each) of an original solution of EDAs (1942 μg mL^−1^) were prepared in PBS in test tubes. To each dilution, a 50 μL of bacteria suspension (OD~600~ = 0.47) in a medium was added, and the mixtures were gently shaken and incubated at 37 °C for 24 h. As a positive reference, 50 μL of ampicillin solution (1000 μg mL^−1^) in a medium was examined in the same way. As a negative control without both lectins and ampicillin, 50 μL of the bacterial suspension (OD~600~ = 0.47) was added to 100 μL of PBS and incubated in the similar way. After incubation, the turbidity of reaction solutions was measured at 600 nm as the index of bacterial growth. The bacterial growth in the presence of EDAs and ampicillin was compared to that in a control. The inhibition activities of EDAs at various concentrations were determined as the ratio (%) to that of ampicillin (1000 μg mL^−1^) and expressed as an efficient concentration (EC~50~) relative to the inhibition activity of ampicillin at 1000 μg mL^−1^.

The antibacterial activity of EDAs was also determined in the presence of yeast mannan, an inhibitor of hemagglutination of EDAs. Briefly, to the serially twofold dilutions (50 μL each) of a EDAs (1942 μg mL^−1^) were prepared in PBS as described above, 50 μL each of yeast mannan (2 mg mL^−1^) in PBS was added. The mixtures were gently shaken and then allowed to stand at room temperature for 1 h. To them, 50 μL each of a bacterial suspension (OD~600~ = 0.47) was added, gently shaken, and incubated at 37 °C overnight. The bacterial growth of each reaction mixture was determined as described above. All assays were carried out in triplicate.

Results {#Sec3}
=======

Extraction and purification of lectins {#Sec4}
--------------------------------------

The lectins from *E. denticulatum* were extracted with aqueous ethanol (about 20 % ethanol concentration) and efficiently recovered as a precipitate with cold 80 % ethanol. The precipitate gave a single active peak in gel filtration (Fig. [1a](#Fig1){ref-type="fig"}). The active fraction was further separated into three active peaks, designated as I, II, and III, by ion-exchange chromatography (Fig. [1b](#Fig1){ref-type="fig"}). The three active peaks gave a single protein band in SDS-PAGE, respectively (Fig. [2a](#Fig2){ref-type="fig"}). The purified lectins thus obtained were named as EDA-1, EDA-2, and EDA-3 in the order of elution from the column. The lectin yields were higher in the order of EDA-2 (13.4 mg), EDA-1 (6.9 mg), and EDA-3 (4.2 mg). The results of purification are summarized in Table [2](#Tab2){ref-type="table"}.Fig. 1**a** Gel filtration of an 80 % ethanol precipitate on a Superdex R 75 HR column (10 × 300 mm). The column was eluted at a flow rate of 1.0 mL min^−1^. Fractions of 1 mL were collected and measured for their absorbance at 280 nm (*closed circles*) and for their hemagglutination activity (*open circles*). **b** Ion-exchange chromatography on a TSKgel DEAE-5PW column (7.5 × 75 mm) of the active peak obtained by gel filtration. The elution was performed at a flow rate of 0.4 mL min^−1^. Fractions of 0.4 mL were collected and measured for their absorbance at 280 nm (*closed circles*) and for their hemagglutination activity (*open circles*). *HU* hemagglutination unit Fig. 2Molecular weight determination of the lectins isolated from *E. denticulatum.* **a** Non-reducing SDS-PAGE for isolated EDAs. *Lane 1*, a mixture of reference proteins; *lane 2*, an active fraction obtained by gel filtration; *lane 3*, EDA-1; *lane 4*, EDA-2; and *lane 5*, EDA-3. From *lane 3* to *lane 5*, active fractions obtained from ion-exchange chromatography. The relative migration of EDAs was not changed in a reducing SDS-PAGE. **b** ESI-MS spectrum of the isolectin EDA-1. An ESI-MS multiply charged spectrum for EDA-1 with average molecular weight of 27,868.0 Da was represented for an example Table 2Summary of purification of the isolectins from *E. denticulatum*. Fresh alga (1 kg) was used as a starting materialExtraction and purification stepProtein (mg)Total activity (× 10^3^ HU^a^ mL^−1^)Specific activity (× 10^3^ HU mg^−1^)Yield (%)Extraction614.4865.31.4100.0Ethanol precipitation85.1654.67.775.6Gel filtration EDAs33.2510.715.459.0Ion exchange EDA-16.9115.016.713.3 EDA-213.4248.218.528.7 EDA-34.278.318.89.1^a^Hemagglutination units (hemagglutination titer)

Molecular mass and N-terminal amino acid sequence {#Sec5}
-------------------------------------------------

The relative molecular masses of the purified lectins were estimated to be about 28 kDa by both non-reducing and reducing SDS-PAGE (Fig. [2a](#Fig2){ref-type="fig"}). They were also determined to be 27,868.0 Da (EDA-1) (Fig. [2b](#Fig2){ref-type="fig"}), 27,834.2 Da (EDA-2), and 27,861.0 Da (EDA-3) by ESI-MS, indicating that their molecular weights are similar to one another but not identical. The purified lectins have no carbohydrate as they did not stain for carbohydrate (data not shown). Thus, the lectins from *E. denticulatum* were commonly monomeric proteins of about 28 kDa. The 20 N-terminal amino acid sequences were also identical among them, except EDA-1 and EDA-3 which have Val in place of Trp at position 16 (Fig. [3](#Fig3){ref-type="fig"}).Fig. 3N-terminal amino acid sequences of the lectins isolated from *E. denticulatum* and the related lectins: *E. serra* (ESA-1 and ESA-2) (Kawakubo et al. [@CR21]); *K. alvarezii* (KAA-1, KAA-2 and KAA-3) (Hung et al. [@CR19]); *K. striatum* (KSA-1, KSA-2 and KSA-3) (Hung et al. [@CR20]). *Underlines* indicate different amino acid residues

Primary structure of EDA-2 {#Sec6}
--------------------------

The isolated full-length cDNA of EDA isolectin consisted of 1158 bp containing 103 bp of a 5′untranslated region (5′UTR), 807 bp of an open reading frame (ORF), and 248 bp of 3′UTR (Fig. [4](#Fig4){ref-type="fig"}). ORF coded a polypeptide of 269 amino acids including an initiating methionine. The calculated molecular mass of the deduce amino acid sequence in EDA isolectin cDNA was 27.834.19 Da, which was consistent with that of EDA-2, 27,834.2 Da, which was determined by ESI-MS. Thus, we concluded the isolated cDNA encoding EDA-2. The 20 N-terminal amino acid sequence of EDA-2, which had been determined by Edman degradation, was found in the deduced amino acid sequence of EDA-2 cDNA. The primary structure of EDA-2 has four tandemly repeated domains, each consisting of 67 amino acids and sharing 47 % sequence identity (Fig. [5](#Fig5){ref-type="fig"}). The homologous sequences were found in database search, including lectins from cyanobacteria *Oscillatoria agardhii* (OAA) (132 aa) (P84330), proteobacteria, *Burkholderia oklahomensis* EO147 (BOA) (276 aa) (ZP_02360833), *Pseudomonas fluorescens* Pf0-1 (PFL) (133 aa) (YP_346241), and *Myxococcus xanthus* (MBHA) (267 aa) (M13831), and from marine red alga *Eucheuma serra* (ESA-2) (268 aa) (P84331). All of them contain four tandemly repeated homologous domains of about 67 amino acids, except OAA and PFL, which are composed of only two tandemly repeated homologous domains. The identity of ESA-2, MBHA, and BOA with EDA-2 in amino acid sequences were 95.2, 59.0, and 57.1 %, respectively, whereas OAA and PFL showed a considerable sequence identity, 61.4 and 63.6 %, to the N-terminal half of EDA-2, respectively (Fig. [6](#Fig6){ref-type="fig"}).Fig. 4Nucleotide and deduced amino acid sequences of EDA-2, a lectin from *E. denticulatum*. The stop codon TAG is shown as an *asterisk*. The *italicized* and *non-italicized* numbers represent the positions of nucleotides and amino acids, respectively Fig. 5Comparison of tandem-repeated sequences of EDA-2. Identical amino acids among the four repeated domains in the lectin molecule are *shaded* Fig. 6Multiple alignment of EDA-2 with related proteins. Multiple sequence alignments were carried out using the CLUSTALW 2.0 program (Larkin et al. [@CR25]). The following sequences were obtained from GenBank database: ESA-2 from *Eucheuma serra* (P84331); MBHA from *Myxococcus xanthus* (YP_635174); BOA from *Burkholderia oklahomensis* EO147 (ZP_02360833); OAA from *Oscillatoria agardhii* (P84330); PFL from *Pseudomonas fluorescens* Pf0-1 (YP_346241). The identical amino acids were indicated by *shade*

Effects of temperature, pH, and metal ions on hemagglutination activity {#Sec7}
-----------------------------------------------------------------------

The purified lectins were relatively thermostable because their hemagglutination activities were unchanged after incubation at 50 °C for 30 min; however, the activities gradually decreased as incubation temperature exceeded 50 °C. Their activities were stable in a wide range of pH from 3 to 10 (Fig. [7](#Fig7){ref-type="fig"}) and were not affected by either presence of EDTA or addition of divalent cations such as Ca^2+^ and Mg^2+^ (data not shown).Fig. 7The effects of temperature and pH on hemagglutination activities of isolectins from *E. denticulatum*. Hemagglutination titer of EDA-1(![](10811_2014_441_Figa_HTML.gif){#d29e1288}), EDA-2(![](10811_2014_441_Figb_HTML.gif){#d29e1291}) and EDA-3(![](10811_2014_441_Figc_HTML.gif){#d29e1294})

Hemagglutination-inhibition test {#Sec8}
--------------------------------

The purified isolectins showed the same hemagglutination-inhibition profiles with a series of sugars and glycoproteins (Table [3](#Tab3){ref-type="table"}). The monosaccharides, lactose, and fucoidan did not inhibit their hemagglutination. Strong inhibition was observed with glycoproteins including yeast mannan, porcine and bovine thyroglobulins, and their asialo-derivatives, all of which have high-mannose type *N*-glycans in the molecules, although both thyroglobulins contain complex type *N*-glycans, too. Transferrin bearing only complex type *N*-glycans was no inhibitory. However, fetuin bearing both complex type *N*-glycans and *O*-glycans and bovine submaxillary mucin bearing *O*-glycans were also moderately inhibitory, although porcine stomach mucin bearing *O*-glycans were no inhibitory. These results suggested that the isolectins are commonly specific for high-mannose *N*-glycans.Table 3Hemagglutination-inhibition test of the three isolectins isolated from *E. denticulatum*. The hemagglutination-inhibition test was carried out as described in the ExperimentalSugar and glycoproteinEDA-1EDA-2EDA-3Sugar (mM) Monosaccharides^a^--^b^---- Lactose------ Fucoidan------Glycoprotein (μg mL^−1^) Transferrin------ Fetuin62.562.562.5 Porcine thyroglobulin1.91.91.9 Asialo-porcine thyroglobulin1.91.91.9 Bovine thyroglobulin7.87.87.8 Asialo-bovine thyroglobulin7.87.87.8 Yeast mannan3.93.93.9 Bovine submaxillary mucin31.231.231.2 Asialo-bovine submaxillary mucin31.231.231.2 Porcine stomach mucin------Values indicate the lowest concentration of sugar (mM) and glycoprotein (μg mL^−1^) at which complete inhibition of hemagglutination (titer 4) was achieved^a^The monosaccharides examined are described in Experimental^b^Indicates no inhibition at 100 mM for monosaccharides and at 2000 μg mL^−1^ for glycoproteins

Oligosaccharide-binding specificity of EDA-2 {#Sec9}
--------------------------------------------

An isolectin, EDA-2 was examined for oligosaccharide-binding specificity by a centrifugal ultrafiltration-HPLC assay with 17 pyridylaminated (PA)-oligosaccharides. The structures of the oligosaccharides used are shown in Fig. [8](#Fig8){ref-type="fig"}. The lectin exclusively bound to high-mannose type *N*-glycans (**3**--**13** in Fig. [8](#Fig8){ref-type="fig"}), but did not bind to other oligosaccharides, including the complex type *N*-glycans (**1**--**2**), oligomannoses (**15**, **16**), and a core pentasaccharide (**17**) (Table [4](#Tab4){ref-type="table"}). The binding activity of EDA-2 was more than 90 % with the PA-oligosaccharides, **4**, **6**, **8**, and **11**, all of which have an exposed (α1-3) Man residue at non-reducing terminus in the D2 arm, while the activity significantly decreased with PA-oligosaccharides, **5**, **7**, **9**, **10**, and **12** (less than 50 %), where the (α1-3) Man residue in the D2 arm was masked by the addition of a non-reducing terminal (α1-2) Man residue. The addition of (α1-2) Man at the terminus of D1 or D3 arm had little effect, as the binding activity was unchangeable with the PA-oligosaccharides **6**, **8**, or **11**. On the other hand, the addition of one (α1-2) Man residue to Man(α1-3)Manβ1-unit in the D1 arm significantly enhanced the binding activity of EDA-2 to high-mannose glycans (Table [4](#Tab4){ref-type="table"}). For instance, the comparison of binding activity between a PA-oligosaccharide **4** (binding activity of 100 %) having one (α1-2) Man residue attached to the Man(α1-3)Manβ1-unit in the D1 arm and a PA-oligosaccharide **3** (55.1 %) being devoid the (α1-2) Man residue in the D1 arm. The similar enhancing effect of the (α1-2) Man residue was also found from the comparison of binding activity between the PA-oligosaccharides having the same residue, **7** (44.5 %) and **9** (43.4 %) and a PA-oligosaccharide without the residue, **12** (21.4 %)Fig. 8The structures of 17 PA-oligosaccharides used in this study. *R*, GlcNAcβ1-4GlcNAc-PA; *Gal*, galactose; *GlcNAc*, *N*-acetylglucosamine; *Man*, mannose; *PA*, pyridylaminated Table 4Oligosaccharide-binding activity of EDA-2OligosaccharidesBinding activity (%)EDA-2ESA-2^a^KSA-2^b^KAA-2^c^Complex type 10.00.010.30.0 20.00.00.00.0High-mannose type 355.179.042.595.8 4100.091.5100.0100.0 540.168.556.617.2 6100.093.4100.0100.0 744.566.446.734.6 898.784.994.676.7 943.369.951.465.0High-mannose type 1054.168.253.749.1 1198.688.2100.074.2 1221.452.828.461.5 1337.179.037.1ND 140.00.00.0NDOligomannose 150.00.00.00.0 160.00.00.00.0Core pentasaccharide 170.00.00.00.0Binding activity was determined by the centrifugal ultrafiltration-HPLC method as described in the Experimental and expressed as a ratio (%) of the amount of a bound oligosaccharide to that of the added oligosaccharide. The structures of PA-oligosaccharides are presented in Fig. [8](#Fig8){ref-type="fig"}*ND* not determined^a^Cited from Hori et al. ([@CR17])^b^Cited from Hung et al. ([@CR20])^c^Cited from Sato et al. ([@CR38])

Antibacterial assay and inhibition of antibacterial activity {#Sec10}
------------------------------------------------------------

The lectin fraction (EDAs) significantly inhibited the growth of *V. alginolyticus* at more than 60.6 μg mL^−1^, whereas it did not affect the growth of *V. parahaemolyticus* and *V. harveyi* even at 1942 μg mL^−1^. The highest concentration of EDAs (1942 μg mL^−1^) suppressed the growth of *V. alginolyticus* to 69 % in comparison to that in the control without EDAs, whereas ampicillin did to 60 % at 1000 μg mL^−1^. The degrees of inhibition at various concentrations of EDAs to that of ampicillin at 1000 μg mL^−1^ were plotted as the inhibition ratios relative to ampicillin (Fig. [9](#Fig9){ref-type="fig"}). The antibacterial activity of EDAs was comparable to that of ampicillin with a relative EC~50~ of 343 μg mL^−1^, although the chemical structures of both compounds are clearly distinct. Interestingly, the growth-inhibition activity of EDAs toward *V. alginolyticus* was lost in the presence of yeast mannan bearing high-mannose *N*-glycans (Fig. [9](#Fig9){ref-type="fig"}) which was the strongest inhibitory glycoprotein toward hemagglutination with EDAs (Table [3](#Tab3){ref-type="table"}).Fig. 9Antibacterial activity and inhibition of antibacterial activity. The growth of *V. alginolyticus* after incubated at 37 °C for 24 h was measured at absorbance of 600 nm. The inhibitory effect of EDAs against the bacteria growth was expressed in percentage where the inhibition effect of 1 mg mL^−1^ ampicillin (a positive control) was hundred percent and that of non-lectin or -ampicillin supplemented solution (a negative control) was zero percent. *White* and *black circles* indicate EDAs treatment (○) and EDAs treatment with yeast mannan (●), respectively

Discussion {#Sec11}
==========

The red alga *E. denticulatum* contained three isolectins which were purified by a combination of extraction with aqueous ethanol, ethanol precipitation, and ion-exchange chromatography. The use of aqueous ethanol was effective to remove viscous algal polysaccharides as previously reported (Hori et al. [@CR15], [@CR16]; Kawakubo et al. [@CR21]). The sum of the yields of the isolated lectins (Table [2](#Tab2){ref-type="table"}) is much lower than those reported for genus *Eucheuma* (Kawakubo et al. [@CR21], [@CR22]) and *Kappaphycus* (Hung et al. [@CR19], [@CR20]).

The lectins isolated from *E. denticulatum* showed similar biochemical properties not only to one another but also to those of lectins from the genera *Eucheuma* (Kawakubo et al. [@CR21], [@CR22]) and *Kappaphycus* (Hung et al. [@CR19], [@CR20]). All of them were monomeric proteins of about 28 kDa and shared almost the same N-terminal amino acid sequences. Their hemagglutination activities were commonly inhibited by glycoproteins bearing high-mannose *N*-glycans (Table [3](#Tab3){ref-type="table"}). The inhibition with *O*-glycans may be caused by non-specific interaction between the lectins and *O*-glycan-linked glycoproteins, which was often observed for many lectins including the *Eucheuma* and *Kappaphycus* lectins (Kawakubo et al. [@CR21], [@CR22]; Hung et al. [@CR19], [@CR20]).

The binding activity of EDA-2 differed among high-mannose *N*-glycans examined, being attributed to subtle differences in the structures of branched oligomannosides (Fig. [8](#Fig8){ref-type="fig"}, Table [4](#Tab4){ref-type="table"}). The binding activity of EDA-2 was considerably decreased when (α1-2)-linked Man is attached at the terminus of D2 arm (**5**, **7**, **9**, **10**, and **12**), whereas it was not affected but rather enhanced by the presence of (α1-2)-linked Man at the terminus of D1 or D3 arm (**4**, **6**, **8**, and **11**). In other words, the attachment of Man (α1-2) at the non-reducing terminus of D2 arm blocked the carbohydrate interaction of EDA-2. This suggests that a C2-OH of the Man (α1-3) residue in the D2 arm may interact directly with the EDA-2 molecule. The Man (α1-3) in the D2 arm may be the primary target for EDA-2 binding because EDA-2 did not interact to the oligosaccharide **14** (0 %) lacking the Man (α1-3) in the D2 arm, whereas it bound to the oligosaccharide **13** (37.1 %) containing this residue, indicating that EDA-2 recognized preferentially the exposed (α1-3) Man in the D2 arm. The similar binding specificity has also been reported for high-mannose binding lectins from the algae such as ESA-2 (Hori et al. [@CR17]), KSA-2 (Hung et al. [@CR20]) and OAA (Sato et al. [@CR37]). On the other hand, the addition of one (α1-2) Man residue to Man(α1-3)Manβ1-unit in the D1 arm notably enhanced the binding activity (binding activity of EDA-2 with PA-oligosaccharides **4** compared to that with **3**), indicating that the (α1-2) Man residue attached at Man(α1-3)Manβ1-unit in the D1 arm serves as another target for enhancing the binding affinity of EDA-2 to oligomannosides. The similar cases have also been reported for the algal lectin ESA-2 (Hori et al. [@CR17]), KSA-2 (Hung et al. [@CR20]), while the binding activity of OAA was not affected by the (α1-2) Man residue(s) in the D1 arm (Sato et al. [@CR37]). In contrast, a leaf lectin CRLL from the land plant *Cycas revoluta*, which belongs to the Jacalin-like superfamily, loses the binding to high-mannose glycans in which a (α1-2) Man residue was attached at Man(α1-3)Manβ1-unit in the D1 arm, indicating that the addition of (α1-2) Man to the core Man(α1-3)Manβ had rather a destructive effect on CRLL recognition (Nakamura et al. [@CR31]).

The high-mannose *N*-glycan recognition profiles basically resemble other lectins from carrageenophytes, including EDA-2, ESA-2 (Hori et al. [@CR17]), KSA-2 (Hung et al. [@CR20]), and KAA-2 (Sato et al. [@CR38]), whose glycan recognition profiles were also similar to that of OAA, a lectin from the cyanobacterium *O. agardhii* (Sato et al. [@CR37]), but clearly differed from those of other high-mannose binding lectins such as griffithsin from the red alga *Griffithsia* sp. (Moulaei et al. [@CR30]), BCA from the green alga *B. coacta* (Sato et al. [@CR39]), cyanovirin-N from the cyanobacterium *Nostoc ellipsosporum* (Boyd et al. [@CR9]), MVL from the cyanobacterium *M. viridis* (Williams et al. [@CR46]), SVN from the cyanobacterium *Scytonema varium* (Bokesch et al. [@CR6]), ASAs from the garlic *A. sativum* (Dam et al. [@CR11]; Bachyhawat et al. [@CR2]), and HRL from the mushroom *Hygrophorus russula* (Suzuki et al. [@CR43]). The high-mannose binding affinities of EDA-2, ESA-2, KSA-2, KAA-2, and OAA were impaired by the addition of the terminal (α1-2) Man in D2 arm, while griffithsin, BCA, cyanovirin-N, SVN, and ASAs preferentially recognized the non-reducing terminal (α1-2) Man of the mannosides such as Man~8~GlcNAc~2~ and Man~9~GlcNAc~2~ (Moulaei et al. [@CR30]; Sato et al. [@CR39]; Botos et al. [@CR8]; Bokesch et al. [@CR6]; Dam et al. [@CR11]). MVL recognized the core tetra- and pentasaccharides of high-mannose *N*-glycans (Williams et al. [@CR46]), and HRL showed the highest affinity for *N*-glycan core structure, Man(α1-6)\[Man(α1-3)\]Man(β1-4)GlcNAc(β1-4)GlcNAc, but had much lower affinity for Man~8~GlcNAc~2~ and Man~9~GlcNAc~2~ (Suzuki et al. [@CR43]). Thus, there seems to be subtle difference in the recognition modes among high-mannose *N*-glycan-binding lectins.

EDAs, the mixture of three isolectins inhibited the growth of the shrimp pathogenic bacterium, *Vibrio alginolyticus*, although it did not affect the growth of *V. parahaemolyticus* and *V. harveyi*. The growth inhibition of *V. alginolyticus* with EDAs was not observed in the presence of yeast mannan bearing high-mannose *N-*glycans, indicating that *V. alginolyticus* have mannoside or mannoside-like structure(s) on the cell surface, which might respond as a receptor(s) for EDAs, while *V. parahaemolyticus* and *V. harveyi* do not have such structure on their cell surfaces*.* The species-specific antibacterial activities have been reported for the lectins from the red algae, *E. serra* and *Galaxaura marginata,* in which both lectins displayed antibacterial activity toward the fish pathogen *V. vulnificus,* but not toward *V. neresis* and *V. pelagius* (Liao et al. [@CR26]). Although antibacterial activities have been reported for lectins from various biological sources (Santi-Gadelha et al. [@CR35]; Charungchitrak et al. [@CR10]; Riera et al. [@CR33]), there seems to be not reported for the growth-inhibiting activity against shrimp and fish pathogens, except the high-mannose *N*-glycan specific lectins from carrageenophytes mentioned above. These algal lectins may be useful to not only clarify the infection mechanism of their marine pathogens but also protect fishes and shellfishes from the infection.

In this study, we have determined the primary structure of EDA-2 (Fig. [4](#Fig4){ref-type="fig"}) and confirmed that it strongly resembles that of ESA-2 (Hori et al. [@CR17]) and MBHA (Romeo et al. [@CR34]; Koharudin et al. [@CR23]) (Fig. [6](#Fig6){ref-type="fig"}), including its molecular size and the presence of four tandemly repeated motifs. Clusters of identical amino acids of EDA-2 were located on both N- and C-terminal regions of each repeated domain, portions of which also correspond to the conserved regions among the four repeated domains of the lectin. Recently, genes coding the lectins belonging to the same lectin family including OAA and ESA-2 have been discovered in several other prokaryotic microorganisms, including cyanobacteria, proteobacteria, chlorobacteria, and in an eukaryotic marine red alga (Sato and Hori [@CR36]; Koharudin et al. [@CR23]). Similar to members of this lectin family, EDA-2 shared a considerable structure similarity and high-mannose *N*-glycan binding specificity with ESA-2 (Hori et al. [@CR17]), BOA (Whitley et al. [@CR45]), OAA (Sato et al. [@CR37]; Sato and Hori [@CR36]), MBHA (Romeo et al. [@CR34]; Koharudin et al. [@CR23]) and PFL (Sato et al. [@CR40]). The lectins in this family are commonly monomeric proteins composed of either two or four tandem repeats of homologous domains, depending on different family members (Sato and Hori [@CR36]; Koharudin et al. [@CR23]). From a comparison of the sequences, it is also speculated that the highly conserved segments in both the N-terminal and C-terminal regions may be involved in the carbohydrate binding (Fig. [6](#Fig6){ref-type="fig"}). Although the high-mannose *N*-glycan recognition profile of EDA-2 was slightly differed from those of the high-mannose binding cyanobacterial lectins such as CV-N (Botos et al. [@CR8]), MVL (Williams et al. [@CR46]) and SVN (Bokesch et al. [@CR6]), EDA-2 has no sequence similarity with these cyanobacterial lectins, except for OAA (Sato et al. [@CR37]). The strict specificity for high-mannose oligosaccharides with very high binding affinities seems to be a common feature among the lectins from lower organisms such as cyanobacteria and algae.

The cultivated *E. denticulatum* from which three isolectins (EDA-1 \~ 3) were isolated is edible. EDAs also inhibited the growth of a marine pathogenic bacterium, *V. alginolyticus* in dose-dependent manner. The oligosaccharide-binding properties and the primary structure of EDA-2 well resemble those of the antiviral lectins which belong to the high-mannose N-glycan specific lectin family in lower organisms (Sato et al. [@CR37], [@CR38]), suggesting that EDA-2 is also predicted to have antiviral and other applicable activities. This study indicates that *E. denticulatum* might become a candidate for a functional food that can prevent virus infection in the future. Clarifying the structural basis of the recognition mode of the carrageenophyte lectins, including *E. denticulatum* lectins, should contribute to demonstrate the biological function(s) as well as application of this lectin group.
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